Oral, non-opioid drug candidate advancing through Phase 1 and nearing completion of the single ascending dose (SAD) portion ...

A new study shows that while decentralized clinical trials (DCTs) are making research more accessible, they also bring ...

New statistical frameworks such as net treatment benefit offer a multidimensional approach to evaluating efficacy, safety, ...

Getting a cancer diagnosis is overwhelming. For many Black patients, it’s not just the disease they’re up against—it’s also ...

We’re aiming to raise $17,000 by August 10, so we can deepen our reporting on the critical stories unfolding right ...

LUCIA pivotal Phase 3 trial enrolled and randomized over 400 patients in seven months, demonstrating continued strong ...

Results from the Phase III ABTECT-1 (NCT05507203) and ABTECT-2 (NCT05507216) trials showed that Abivax’s obefazimod demonstrated significant clinical remission in patients with ulcerative colitis.

MN-166 COMBAT ALS trial down to single digit required enrollment while MN-001 hypertriglyceridemia trial in type 2 diabetes ...

Gen Li, president and founder of Phesi, spoke with Pharmaceutical Executive about issues pharma companies are having during ...

There is an urgent need for more inclusive and community-focused cancer clinical trials, according to Kimberly (Cary) ...

Q2 2025 has demonstrated the pharmaceutical industry’s continued momentum in developing transformative therapies across ...

Excessive levels of GABA released by astrocytes impair the brain's ability to extinguish fear responses in PTSD, but a newly ...